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Back in the day (there I go again, but bear with me), when I was an executive running the STM portion of a publishing 
house — Wiley, to be specific — I didn’t get 
myself involved in making an acquisition of 
another publisher, or a list of books or journals 
from another publisher.  Maybe it was my 
engineering background.  I was always more 
excited by creating something new, rather than 
buying what someone else had created.
There can be financial advantages, of 
course, to buying rather than creating.  A jour-
nals list can be especially attractive because 
you can combine back office operations, there-
by reducing expenses, while you add revenue. 
A lure of acquiring a books list is the author 
contracts for titles that haven’t been published 
yet.  Think about efficient use of resources: for 
the time being, at least, you can get along with 
the same number of editors while increasing 
the number of titles in the pipeline.
Despite my predilection for creating rather 
than buying, I didn’t labor under any absurd 
presumption that I could, all by myself, corner 
the market on dreaming up new titles for books, 
journals or any other type of STM publication. 
I had enough experience as an acquisitions edi-
tor earlier in my publishing career to know that 
potential authors would be the source of many 
of the ideas for successful new titles.  And it 
was my team of editorial managers and editors 
who would query academics and practitioners 
about what books and other publications upper 
level students and practitioners needed in their 
disciplines.
The team, comprised of a couple of dozen 
seasoned professionals, was adept at finding 
and signing up authors for new book projects 
and seeing to it that they were actually deliv-
ered and published.  At the same time, I recog-
nized that if I were to quickly grow the busi-
ness segment I was responsible for, I needed 
subscription-based products that would make a 
bigger impact than typical journals, which tend 
to add new subscribers rather slowly.
As it happened, I got lucky.  A young wom-
an named Sarah Greene, who had been a life 
sciences editor at Macmillan, walked into my 
office one day with a subscription project called 
Current Protocols in Molecular Biology.  The 
authors, who had appointments at Harvard 
Medical School and Massachusetts General 
Hospital, had convinced Sarah that because 
their field was so dynamic, an ordinary bound 
book would be inadequate.  It would be out of 
date before it went to press.  Loose-leaf pub-
lishing was the only way to go, they told her. 
(This was in the pre-CD-ROM and subsequent 
Internet days.)  
When Sarah’s bosses at Macmillan told 
her that loose-leaf publishing was fraught with 
fulfillment problems, she quit her job and struck 
out on her own.  Sarah convinced me that the 
molecular biology field was indeed exploding 
and that a subscription publication would best 
meet the needs of experimenters and researchers 
in search of the latest and most successful exper-
imental techniques.  It did turn out that Sarah’s 
Macmillan bosses had been right about loose-
leaf fulfillment costs.  But I was right to accept 
her characterization of the molecular biology 
field, and we got 10,000 subscribers by the end 
of the first year.  It came as no surprise to me that 
because of the growing pains associated with a 
fledgling fulfillment operation I had to defend 
the project against senior management’s con-
demnation.  But I did prevail, and the molecular 
biology project became the first of an extensive 
series of protocols publications.
I treated Sarah as a business partner sharing 
in profits, not as an author receiving royalties 
based on a percentage of net sales.  I called 
our partnership a “joint venture.”  It was the 
first of five  joint ventures that I developed 
over the next several 
years.  (The second 
one, which had lovely 
side benefits, was with 
a Paris-based company. 
We published the Crop 
Protection Chemical 
Reference, an annual directory in which man-
ufacturers paid to have their products listed.) 
Publishers Weekly got wind of these activities 
and published a full-page article about them. 
When I showed the article to my boss, he 
scoffed at it.  I didn’t catch on right away, but 
the handwriting was on the wall in caps, and 
my days at that position were numbered indeed.
Truth be told, while I was running STM 
publishing at Wiley, I did look into acquiring 
a few book publishers, including CRC Press 
(when it was rather small and was reliant 
on sales of the Handbook of Chemistry and 
Physics, formerly known as the Chemical and 
Rubber Company Handbook of Chemistry and 
Physics), Birkhauser (then an independent 
Swiss publisher with an office in the Boston 
area), and a small fiefdom called Noyes Pub-
lications, run by a crusty old gent named Bob 
Noyes.  He ran the business out of a large 
building he owned (it was a valuable piece of 
real estate) in downtown Saddle River, NJ.  (I 
can still remember a framed photo he displayed 
of his wife with Dick Nixon.)  The list included 
a mixture of original titles and reprinted gov-
ernment reports.  Annual sales were a couple 
of million dollars.
After I left Wiley and established a con-
sulting practice, I became interested in acqui-
sitions, for the simple reason that brokering 
them could be lucrative.  But I didn’t focus on 
them until one day in the latter 1990s when Bob 
Noyes phoned to say that he wanted to sell his 
business.  It was now half the size it had been 
when I’d last looked at it;  the government re-
prints part had withered away.  Still, I thought I 
could find a buyer, and I prepared a prospectus.
Every so often, I would drive out from my 
Manhattan apartment to New Jersey to discuss 
with Bob my lack of progress in finding a 
buyer for his business.  He’d buy me lunch and 
then I would get lost in northern New Jersey’s 
winding residential streets as I tried to make my 
way north to spend weekends with my future 
wife, who lived near Albany.  Throughout the 
1990s, I was going to the Frankfurt Book 
Fair to drum up consulting business.  I had 
no success, until a friend introduced me to 
Norman Rentrop, a German publisher, and I 
picked up a nice consulting assignment.  On 
that same trip, I came across the stand of a little 
company called William Andrew, which was 
looking to increase its sales.  
Long story short, I brokered a deal between 
Bob Noyes and the two young guys who ran 
William Andrew — Bill Woishnis, who had 
started the company with plastics data books 
that he put together himself, and Chris Forbes, 
who was originally Canadian and, I gathered, 
had bought into the 
company.  Bob Noyes 
suffered from a case 
of cold feet in the days 
right before the clos-
ing, but the acquisition 
did come together at a 
price that satisfied both sides and provided me 
with a nice fee.  
For the next year or two, while Bill and 
Chris kept the Noyes operation in New Jersey, 
I helped build up their publishing business.  I 
also spent time at their main operation in Nor-
wich, NY, near Oneonta, and got to know them 
better — Bill especially, who had a young son. 
Over the next eight to ten years, I met up with 
both Bill and Chris fairly regularly, although 
more often with Bill.  He and I worked together 
on the idea for the first of two engineering 
handbooks I published with William Andrew. 
We would have dinner together during PSP 
Annual Conferences in February.
I watched from afar when Bill and Chris 
developed Knovel, their online book service. 
One of the last times I saw Bill was in Albany. 
(I’d decided, during the days when Bob Noyes 
seemed to be pulling back from selling his 
company and my payday seemed to be evapo-
rating, to move up there to join my future wife 
full time).  Bill introduced me to the Elsevier 
executive who was in charge of the William 
Andrew list, which Elsevier had purchased.  (I 
now publish three handbooks with Elsevier.) 
Another time, I drove out to Oneonta for lunch 
with Bill to talk about the circumstances of his 
having left Knovel, which was now solely in 
Chris’s hands.  Then one day someone called 
me to tell me that Bill had been waiting for his 
son to be finished with an appointment in One-
onta and had been walking in a park, when he 
suddenly collapsed and died of a heart attack. 
He was only 50.
In the end, Elsevier acquired Knovel, in 
addition to the William Andrew list.  With 
ScienceDirect, into which they’d poured over a 
hundred and seventy million dollars, they now 
had, I thought, the best of both possible create 
or buy worlds.  
